Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vecihi Batuman

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
The American Journal of the Medical Sciences|May 25, 2021
The Effect of Proton Pump Inhibitor Use on the Course of Kidney Function in Patients with Chronic Kidney Disease Stages G3a to G4Sixto Giusti, Yilu Lin, Folarin Sogbetun, et al.
Nephrology (Carlton, Vic.)|January 24, 2009
Microalbuminuria as a possible marker of risk of Balkan endemic nephropathyGoran Imamovic, Vecihi Batuman, Osman Sinanovic, et al.
Peptides|December 26, 2009
Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injuryMin Li, Saravanan Balamuthusamy, Altaf M Khan, et al.
Peptides|October 2, 2012
Delayed administration of pituitary adenylate cyclase-activating polypeptide 38 ameliorates renal ischemia/reperfusion injury in mice by modulating Toll-like receptorsAltaf-M Khan, Min Li, Solange Abdulnour-Nakhoul, et al.
Nephron. Experimental Nephrology|July 1, 2010
Myeloma light chain-induced renal injury in miceAltaf-M Khan, Min Li, Saravanan Balamuthusamy, et al.
The American Journal of the Medical Sciences|December 20, 2007
Parathyroid hormone status does not influence blood and bone lead levels in dialysis patientsJhumka Ghosh-Narang, Tiffany M Jones, Andy Menke, et al.
Journal of Molecular Neuroscience : MN|June 2, 2010
Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failureMin Li, Saravanan Balamuthusamy, Altaf M Khan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2004
The risk for mild kidney function decline associated with illicit drug use among hypertensive menSuma Vupputuri, Vecihi Batuman, Paul Muntner, et al.
Transplantation|June 14, 2012
Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodiesIvo Lukitsch, Jasmin Kehr, Lyubov Chaykovska, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2003
Insulin resistance and risk of chronic kidney disease in nondiabetic US adultsJing Chen, Paul Muntner, L Lee Hamm, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
The American Journal of the Medical Sciences|May 25, 2021
The Effect of Proton Pump Inhibitor Use on the Course of Kidney Function in Patients with Chronic Kidney Disease Stages G3a to G4Sixto Giusti, Yilu Lin, Folarin Sogbetun, et al.
Nephrology (Carlton, Vic.)|January 24, 2009
Microalbuminuria as a possible marker of risk of Balkan endemic nephropathyGoran Imamovic, Vecihi Batuman, Osman Sinanovic, et al.
Peptides|December 26, 2009
Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injuryMin Li, Saravanan Balamuthusamy, Altaf M Khan, et al.
Peptides|October 2, 2012
Delayed administration of pituitary adenylate cyclase-activating polypeptide 38 ameliorates renal ischemia/reperfusion injury in mice by modulating Toll-like receptorsAltaf-M Khan, Min Li, Solange Abdulnour-Nakhoul, et al.
Nephron. Experimental Nephrology|July 1, 2010
Myeloma light chain-induced renal injury in miceAltaf-M Khan, Min Li, Saravanan Balamuthusamy, et al.
The American Journal of the Medical Sciences|December 20, 2007
Parathyroid hormone status does not influence blood and bone lead levels in dialysis patientsJhumka Ghosh-Narang, Tiffany M Jones, Andy Menke, et al.
Journal of Molecular Neuroscience : MN|June 2, 2010
Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failureMin Li, Saravanan Balamuthusamy, Altaf M Khan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2004
The risk for mild kidney function decline associated with illicit drug use among hypertensive menSuma Vupputuri, Vecihi Batuman, Paul Muntner, et al.
Transplantation|June 14, 2012
Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodiesIvo Lukitsch, Jasmin Kehr, Lyubov Chaykovska, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2003
Insulin resistance and risk of chronic kidney disease in nondiabetic US adultsJing Chen, Paul Muntner, L Lee Hamm, et al.
Pageof 8